David Novack's Insider Trades & SAST Disclosures
David Novack's most recent trade in Dynavax Technologies Corp. was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Novack.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 10,000 | 186,528 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 24 Mar 2025 | 10,000 | 18,078 (0%) | 0% | 6.8 | 68,050 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 24 Mar 2025 | 10,000 | 8,078 (0%) | 0% | 14 | 140,000 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 13.58 per share. | 18 Mar 2025 | 14,020 | 8,078 (0%) | 0% | 13.6 | 190,392 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 14.39 per share. | 07 Mar 2025 | 32,764 | 22,098 (0%) | 0% | 14.4 | 471,474 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 22,620 | 45,240 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 22,620 | 65,527 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.93 per share. | 18 Feb 2025 | 10,665 | 54,862 (0%) | 0% | 12.9 | 137,898 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 93,000 | 93,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 56,364 | 56,364 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 26,500 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 26,500 | 26,500 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 26,500 | 54,156 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.69 per share. | 13 Feb 2025 | 12,480 | 42,907 (0%) | 0% | 12.7 | 158,371 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 8,833 | 32,174 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 8,833 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.20 per share. | 10 Feb 2025 | 4,518 | 27,656 (0%) | 0% | 13.2 | 59,638 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 95,000 | 95,000 | - | - | Stock Options (Right to Buy) | |
| Dynavax Technologies Corp. | Novack David | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 67,860 | 67,860 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Novack David | President & COO | Grant, award, or other acquisition of securities at price $ 9.45 per share. | 15 Feb 2024 | 1,207 | 22,090 (0%) | 0% | 9.4 | 11,406 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 8,833 | 8,833 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 8,833 | 24,034 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Novack David | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.82 per share. | 10 Feb 2024 | 3,151 | 20,883 (0%) | 0% | 12.8 | 40,396 | Common Stock |
| Dynavax Technologies Corp. | Novack David | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 17,500 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | Novack David | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 17,500 | 21,889 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | Novack David | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.79 per share. | 03 Feb 2024 | 6,688 | 15,201 (0%) | 0% | 12.8 | 85,540 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.42 per share. | 02 Jan 2024 | 9,000 | 12,187 (0%) | 0% | 5.4 | 48,780 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 9,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 14.45 per share. | 02 Jan 2024 | 9,000 | 3,187 (0%) | 0% | 14.5 | 130,050 | Common Stock |
| Dynavax Technologies Corp. | Novack David | President & COO | Sale of securities on an exchange or to another person at price $ 13.56 per share. | 01 Dec 2023 | 20,000 | 3,187 (0%) | 0% | 13.6 | 271,200 | Common Stock |
| Dynavax Technologies Corp. | Novack David | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.42 per share. | 01 Dec 2023 | 20,000 | 23,187 (0%) | 0% | 5.4 | 108,400 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 20,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.81 per share. | 08 Aug 2023 | 25,000 | 28,187 (0%) | 0% | 3.8 | 95,250 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 08 Aug 2023 | 20,000 | 3,187 (0%) | 0% | 15.0 | 300,200 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.42 per share. | 08 Aug 2023 | 15,000 | 43,187 (0%) | 0% | 5.4 | 81,300 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 15,000 | 121,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 14.73 per share. | 08 Aug 2023 | 10,000 | 23,187 (0%) | 0% | 14.7 | 147,300 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 14.74 per share. | 08 Aug 2023 | 10,000 | 33,187 (0%) | 0% | 14.7 | 147,400 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 10.90 per share. | 04 May 2023 | 17,515 | 3,187 (0%) | 0% | 10.9 | 190,914 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 17,500 | 17,500 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 17,500 | 29,292 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 8,834 | 16,639 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 8,750 | 11,937 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 8,590 | 20,702 (0%) | 0% | 10.4 | 88,992 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 8,334 | 17,666 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 4,847 | 11,792 (0%) | 0% | 10.4 | 50,215 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.36 per share. | 27 Feb 2023 | 4,132 | 7,805 (0%) | 0% | 10.4 | 42,808 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 9.73 per share. | 16 Feb 2023 | 1,121 | 3,187 (0%) | 0% | 9.7 | 10,907 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 8,750 | 8,750 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 12.47 per share. | 08 Nov 2022 | 52,204 | 2,066 (0%) | 0% | 12.5 | 650,984 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 10.29 per share. | 08 Nov 2022 | 1,057 | 54,270 (0%) | 0% | 10.3 | 10,877 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 26,250 | 8,750 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 16.92 per share. | 08 Aug 2022 | 26,250 | 53,213 (0%) | 0% | 16.9 | 444,037 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 26,250 | 79,463 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 05 Aug 2022 | 20,000 | 53,213 (0%) | 0% | 16 | 320,000 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 52,500 | 96,566 (0%) | 0% | - | Common Stock | |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 52,500 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,500 | 26,500 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 20.12 per share. | 01 Nov 2021 | 20,000 | 44,066 (0%) | 0% | 20.1 | 402,400 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 07 Oct 2021 | 3,000 | 64,066 (0%) | 0% | 18 | 54,000 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 18.23 per share. | 01 Oct 2021 | 17,000 | 67,066 (0%) | 0% | 18.2 | 309,844 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 19.99 per share. | 01 Sep 2021 | 20,000 | 84,066 (0%) | 0% | 20.0 | 399,770 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 23 Aug 2021 | 10,000 | 104,066 (0%) | 0% | 14 | 140,000 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. | 23 Aug 2021 | 4,167 | 114,066 (0%) | 0% | 4.5 | 18,752 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 4,167 | 0 | - | - | Warrant (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 23 Aug 2021 | 2,500 | 109,899 (0%) | 0% | 3.4 | 8,479 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 11 Aug 2021 | 10,000 | 107,399 (0%) | 0% | 12 | 120,000 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Sale of securities on an exchange or to another person at price $ 9.92 per share. | 01 Apr 2021 | 20,000 | 117,399 (0%) | 0% | 9.9 | 198,400 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 01 Apr 2021 | 2,500 | 137,399 (0%) | 0% | 3.4 | 8,475 | Common Stock |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 52,500 | 52,500 | - | - | Restricted Stock Unit | |
| Dynavax Technologies Corp. | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 03 Feb 2021 | 2,500 | 134,899 (0%) | 0% | 3.4 | 8,475 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges